Moteur de recherche d’entreprises européennes
Financement de l’UE (2 903 863 €) : Le biofilm bactérien comme bio-usine pour la régénération des tissus Hor01/04/2023 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Le biofilm bactérien comme bio-usine pour la régénération des tissus
BIOACTION aims at developing a new methodology in implant technology based on functionalized bio-hydrogels that will convert the negative occurrence of biofilm-associated infections, the primary cause of implant infections and failure, into a positive resource. The main goal of BIOACTION is to transform implant-associated bacteria for the programmable production of specific proteins for in vivo cell recruitment and tissue regeneration, exploiting gene sequences loaded on engineered liposomes and phages, bound to hydrogel scaffolds. BIOACTION will develop new biomimetic substrates that can transform biofilm into extracellular matrix for the regeneration of target tissues. It will establish a high versatile technology to be used as injectable materials and implant coatings for periodontal and peri-implant infection treatments. The proposed approach will be validated in two clinically relevant animal models: dental implant and permanent transcutaneous bone. BIOACTION, would radically advance the future of infection treatment by revolutionizing the classical approaches leading to the improvement of state of care, health outcomes and to achieve huge socio-economic benefits. The project isstrongly interdisciplinary in nature involving expertise biomaterials, synthetic biology, phage and liposome technology, medicine. As a results, this innovative approach will bring the research and knowledge far beyond the current state-of-the-art and will lead, through the planned validation, as proof-of-concept of new materials and technique with a broader application in regenerative medicine.
| АО FORSCHUNGSINSTITUT DAVOS | ? |
| Consiglio Nazionale Delle Ricerche | 776 250 € |
| FERENTIS | 412 500 € |
| Fundacio Institut de Bioenginyeria de Catalunya | 352 113 € |
| IN Srl | 251 250 € |
| Universita Degli Studi Del Piemonte Orientale Amedeo Avogadro | 493 750 € |
| Universite de Liege | 618 000 € |
https://cordis.europa.eu/project/id/101098972
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : AO Forschungsinstitut Davos, Davos Platz, Suisse.
